MED-EL Corporation Announces FDA Approval of Expanded Candidacy Indications and Hearing Preservation Results for the MED-EL Cochlear Implant System. November 13, 2024 08:02 AM Eastern Standard Time.

North Carolina-based hearables company, MED-EL Corporation, has secured clearance from the US Food and Drug Administration (FDA) for a range of new indications alongside the approval of hearing ...

DURHAM, N.C.--(BUSINESS WIRE)--Hearing implant leader, MED-EL Corporation USA, today announced the launch of the world’s first single-unit processor for cochlear implants, the RONDO™.

MED-EL Corporation announced today new data regarding FineHearing technology, available only with the MAESTRO cochlear implant system. In addition to hearing in "high definition" with FineHearing ...

MED-EL Corporation has developed a novel Fine Hearing technology that can enable profoundly deaf people to enjoy music and hear clearly in noisy environments - two areas of hearing ...

With the help of Microstate and MED-EL, an expert team of audiologists from the Medical College of Virginia and UNC-Chapel Hill have provided remote support to an audiologist in Columbia, South ...

SYNCHRONY EAS (Electric Acoustic Stimulation) Hearing Implant System, which is manufactured by Durham-based MED-EL Corporation, received FDA approval and benefits patients with advanced hearing loss.

DURHAM, N.C., November 13, 2024--(BUSINESS WIRE)--Hearing implant leader MED-EL Corporation announced today the U.S. Food and Drug Administration (FDA) approval of new indications along with the ...

North Carolina-based hearables company, MED-EL Corporation, has secured clearance from the US Food and Drug Administration (FDA) for a range of new indications alongside the approval of hearing ...